Netherlands
The Biotechnology company in Netherlands with the highest Capital Expenditure To Sales 5 year CAGR is Uniqure NV (NASDAQ: QURE) at 3.72%.
The Biotechnology company in Netherlands with the lowest Capital Expenditure To Sales 5 year CAGR is Uniqure NV (NASDAQ: QURE) at 3.72%.
The top 10 Biotechnology companies in Netherlands by Capital Expenditure To Sales 5 year CAGR are and Uniqure NV.
The bottom 10 Biotechnology companies in Netherlands by Capital Expenditure To Sales 5 year CAGR are and Uniqure NV.